Vanguard Group Inc Standard Biotools Inc. Transaction History

Vanguard Group Inc

$4.96 Trillion
Q1 2024

A detailed history of Vanguard Group Inc transactions in Standard Biotools Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 13,034,043 shares of LAB stock, worth $23.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,034,043

Previous 4,133,939 215.29%

Holding current value

$23.1 Million

Previous $9.14 Million 286.62%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.87 - $2.78 $16.6 Million - $24.7 Million	8,900,104 Added 215.29%	13,034,043 $35.3 Million
Q4 2023 Feb 14, 2024	BUY	$1.59 - $2.73 $253,466 - $435,197	159,413 Added 4.01%	4,133,939 $9.14 Million
Q3 2023 Nov 14, 2023	BUY	$1.9 - $3.05 $60,108 - $96,489	31,636 Added 0.8%	3,974,526 $11.5 Million
Q2 2023 Aug 14, 2023	SELL	$1.47 - $2.56 $19,224 - $33,479	-13,078 Reduced 0.33%	3,942,890 $7.61 Million
Q4 2022 Feb 10, 2023	BUY	$0.93 - $1.52 $1,501 - $2,453	1,614 Added 0.04%	3,955,968 $4.63 Million

Q3 2022 Nov 14, 2022	BUY	$1.22 - $2.06 $484,096 - $817,408	396,800 Added 11.15%	3,954,354 $4.35 Million
Q2 2022 Aug 12, 2022	SELL	$1.6 - $3.99 $574,844 - $1.43 Million	-359,278 Reduced 9.17%	3,557,554 $5.69 Million
Q1 2022 May 13, 2022	BUY	$2.8 - $3.96 $137,650 - $194,677	49,161 Added 1.27%	3,916,832 $14.1 Million
Q4 2021 Feb 14, 2022	BUY	$3.63 - $6.13 $1.02 Million - $1.72 Million	280,792 Added 7.83%	3,867,671 $15.2 Million
Q3 2021 Nov 12, 2021	SELL	$5.5 - $7.41 $423,313 - $570,318	-76,966 Reduced 2.1%	3,586,879 $23.6 Million
Q2 2021 Aug 13, 2021	BUY	$4.35 - $6.35 $15.9 Million - $23.3 Million	3,663,845 New	3,663,845 $22.6 Million

Others Institutions Holding LAB

# of Institutions

146

Shares Held

265M

Call Options Held

356K

Put Options Held

400

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $139M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Standard Biotools Inc. Transaction History